Respiratory Syncytial Virus: New perspectives for development of a vaccine

16 octubre 2014

Respiratory Syncytial Virus causes severe respiratory tract infections and worldwide claims the lives of 160,000 children each year. Scientists have succeeded in developing a promising vaccination strategy to counteract this common virus infection. “We discovered a new vaccination strategy that paves the way for the development of a novel approach to vaccination against RSV, a virus that causes suffering in numerous small children and elderly people,” experts report.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/lGDCFjb-wZQ/141016085408.htm

Volver